Cyclopentobarbital
Chemical compound
- None
- CA: Schedule IV
- 5-(1-cyclopent-2-enyl)-5-prop-2-enyl-1,3-
diazinane-2,4,6-trione
- 76-68-6
302-34-1 (sodium salt)
- 6454
- 6212
Y
- 2230XWG55Q
- Interactive image
- O=C1NC(=O)NC(=O)C1(C2/C=C\CC2)C\C=C
InChI
- InChI=1S/C12H14N2O3/c1-2-7-12(8-5-3-4-6-8)9(15)13-11(17)14-10(12)16/h2-3,5,8H,1,4,6-7H2,(H2,13,14,15,16,17)Y
- Key:XOVJAYNMQDTIJD-UHFFFAOYSA-NY
Cyclopentobarbital sodium (Cyclopal, Dormisan) is a barbiturate derivative invented in the 1940s.[1] It has sedative and anticonvulsant properties, and was used primarily as an anaesthetic in veterinary medicine.[2] Cyclopal is considered similar in effects to phenobarbital but lasts almost three times as long, and is considered a long-acting barbiturate with a fairly slow onset of action.
See also
- Barbiturate
References
- ^ Martin JR, Godel T, Hunkeler W, Jenck F, Moreau JL, Sleight AJ, Widmer U (December 2000). "Psychopharmacological agents.". Kirk-Othmer Encyclopedia of Chemical Technology. doi:10.1002/0471238961.1619250313011820.a01. ISBN 0471238961.
- ^ Vander Brook MJ, Cartland GF (1944). "A Pharmacologic Study of 5-Allyl-5-Cyclopentenyl Barbituric Acid (Cyclopal)". Journal of Pharmacology and Experimental Therapeutics. 80 (2): 119–125. CiteSeerX 10.1.1.983.6071.
- v
- t
- e
General anesthetics (N01A)
| Phenols | |
|---|---|
| Barbiturates | |
| Benzodiazepines | |
| Opioids | |
| Arylcyclohexylamines | |
| Neuroactive steroids | |
| Others |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This sedative-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
